Uncategorized

CHP Co-Founder and Partner Joseph Swedish Named to Accelus Board of Directors PALM BEACH GARDENS, Fla., July 12, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the closing of a $12 million lead …

Accelus Announces Series D Equity Financing Led by Concord Health Partners (CHP) Read More »

All New Gallery Lisa Jacobs promoted to serve as Vice President of Sales Jim Fox promoted to East U.S. Vice President of Sales Jay Shellhammer promoted to West U.S. Vice President of Sales PALM BEACH GARDENS, Fla., June 13, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption …

Accelus Announces Sales Leadership Appointments, Establishes U.S. East and West Sales Leaders Read More »

New offices provide additional resources for clinical education, surgical training, and robotic research and development PALM BEACH GARDENS, Fla., May 26, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the opening of its new robotic …

Accelus Announces Opening of New Facilities in Colorado and California Read More »

PALM BEACH GARDENS, Fla., May 19, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Toro Lateral (Toro-L) …

Accelus Receives U.S. FDA 510(k) Clearance for its Toro-L Interbody Fusion System Read More »

PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its FlareHawk TiHawk™11 Interbody …

Accelus Receives U.S. FDA 510(k) Clearance for its FlareHawk TiHawk11 Interbody Fusion System Read More »

TiHawk7 combines ultra-low 7mm insertion profile with strong titanium/PEEK adhesion while still allowing for radiographic verification of fusion PALM BEACH GARDENS, Fla., May 5, 2022 (GLOBE NEWSWIRE) – Accelus, a medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the alpha launch …

Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures Read More »

Leading medical technology company recognized for employee engagement and culture PALM BEACH GARDENS, Fla., May 02, 2022 (GLOBE NEWSWIRE) — Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has been recognized by The Sun Sentinel …

Sun Sentinel Names Accelus a Winner of the South Florida Top Workplaces 2022 Award Read More »

PALM BEACH GARDENS, Fla., April 21, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the successful completion of the first surgery integrating its Remi™ Robotic Navigation, LineSider® Spinal System, and FlareHawk® Expandable Interbody …

Accelus Announces First Procedure Integrating Remi Robotic Navigation System, LineSider Spinal System, and FlareHawk Expandable Interbody Fusion Device Technologies Read More »

Distinguished neurosurgeon-inventor to lead continued development of Accelus’s Remi™ Robotic Navigation System PALM BEACH GARDENS, Fla., April 18, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the appointment of Kevin Foley, MD, as …

Accelus Appoints Kevin Foley, MD as Chief Robotics Officer Read More »

Innovative new robotic targeting and navigation system provides precision, accessibility Palm Beach Gardens, FL / Summit, NJ, March 10, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the successful completion of the first cases utilizing …

Accelus Announces Successful First Surgeries Using Remi Robotic Navigation System with LineSider Spinal System Read More »